Bio-Techne
TECH
#1486
Rank
โ‚น991.46 B
Marketcap
โ‚น6,240
Share price
2.49%
Change (1 day)
-3.42%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

Revenue for Bio-Techne (TECH)

Revenue in 2024 (TTM): โ‚น97.74 Billion

According to Bio-Techne's latest financial reports the company's current revenue (TTM ) is โ‚น99.91 Billion. In 2023 the company made a revenue of โ‚น95.31 Billion an increase over the revenue in the year 2022 that were of โ‚น92.66 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Bio-Techne from 1996 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚น97.74 B2.54%
2023 โ‚น95.31 B2.86%
2022 โ‚น92.66 B20.92%
2021 โ‚น76.63 B31.15%
2020 โ‚น58.43 B10.03%
2019 โ‚น53.10 B11.41%
2018 โ‚น47.66 B24.55%
2017 โ‚น38.27 B6.64%
2016 โ‚น35.88 B16.11%
2015 โ‚น30.90 B19.38%
2014 โ‚น25.89 B26.93%
2013 โ‚น20.39 B19.24%
2012 โ‚น17.10 B5.48%
2011 โ‚น16.21 B32.74%
2010 โ‚น12.21 B-0.57%
2009 โ‚น12.28 B-4.79%
2008 โ‚น12.90 B37.73%
2007 โ‚น9.36 B-0.09%
2006 โ‚น9.37 B8.98%
2005 โ‚น8.60 B18.15%
2004 โ‚น7.28 B4.26%
2003 โ‚น6.98 B5.73%
2002 โ‚น6.60 B12.3%
2001 โ‚น5.88 B16.18%
2000 โ‚น5.06 B19.08%
1999 โ‚น4.25 B26.44%
1998 โ‚น3.36 B34.77%
1997 โ‚น2.49 B20.31%
1996 โ‚น2.07 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚น3.613 T 3,516.47%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น220.03 B 120.23%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1.720 T 1,622.29%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1.708 T 1,609.65%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น167.67 B 67.82%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
โ‚น4.640 T 4,544.23%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น2.72 B-97.28%๐Ÿ‡บ๐Ÿ‡ธ USA